Image of drugs on a platform

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to…
Medical imaging of the human heart

Monash tests show strong cardioprotective qualities for Algorae drug candidate

Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168
The Market Online Video

How to negotiate your future

Negotiation is a vital skill no matter whether you’re an employee, business owner or investor. It’s…